<DOC>
	<DOCNO>NCT02088151</DOCNO>
	<brief_summary>Laser photocoagulation retina target outer layer establish therapy proliferative retinopathy macular edema diabetic microangiopathy retinal vein occlusion , central serous retinopathy , extrafoveal subretinal neovascular membrane . However , collateral damage occur scotomas result use conventional laser pulse duration 100ms . This particularly relevant laser treatment macula main therapeutic effect result stimulation retinal pigment epithelium cell photoreceptor damage think unnecessary side effect . Recent experimental research new laser device use much short pulse duration show photoreceptor damage greatly reduce retinal pigment epithelium selectively target , hence term selective retinal pigment epithelium laser therapy ( SRT ) . Investigators hypothesize SRT equally effective standard laser photocoagulation macular disease minimize local visual field defect . In study , patient central serous retinopathy , macular edema diabetic microangiopathy branch vein occlusion , non-exudative age-related macular degeneration treat SRT . Patients assess 1 , 3 6 month treatment .</brief_summary>
	<brief_title>Selective Retinal Pigment Epithelium Laser Therapy Macular Disease Retina</brief_title>
	<detailed_description>Background Laser photocoagulation retina target outer layer establish therapy proliferative retinopathy macular edema diabetic microangiopathy retinal vein occlusion , central serous retinopathy , extrafoveal subretinal neovascular membrane . However , collateral damage occur scotomas result use conventional laser pulse duration 100ms . This particularly relevant laser treatment macula main therapeutic effect result stimulation retinal pigment epithelium cell photoreceptor damage think unnecessary side effect . Recent experimental research new laser device use much short pulse duration show photoreceptor damage greatly reduce retinal pigment epithelium selectively target , hence term selective retinal pigment epithelium laser therapy ( SRT ) . In age-related macular degeneration , regression drusen observe laser treatment convention laser SRT . Investigators hypothesize SRT equally effective standard laser photocoagulation macular disease minimize local visual field defect . Objective To assess efficacy SRT patient central serous retinopathy , macular edema diabetic microangiopathy branch vein occlusion , non-exudative age-related macular degeneration . Up five patient proliferative diabetic retinopathy optionally treat SRT . Methods At baseline follow-up patient receive full ophthalmic examination include optical coherence tomography , fundus autofluorescence imaging , fluorescein angiography ( FA ) , visual acuity test . SRT ( R : GEN Laser System Lutronic Corporation , Korea ) deliver topical anesthesia . For titration energy spot first apply outside major arcade . Immediately thereafter FA perform extrapolation laser dose , since treatment sub-threshold laser spot visible biomicroscopically . The patient treat discretion ophthalmologist 500 laser burn . One hour laser treatment FA repeat confirm treatment effect . Patients assess 1 , 3 6 month treatment . Pulse duration choose 200ns 2Î¼s . The maximum pulse energy 1mJ . 1-30 pulse apply every laser burn frequency 100Hz .</detailed_description>
	<mesh_term>Macular Degeneration</mesh_term>
	<mesh_term>Macular Edema</mesh_term>
	<mesh_term>Neovascularization , Pathologic</mesh_term>
	<mesh_term>Retinal Vein Occlusion</mesh_term>
	<mesh_term>Central Serous Chorioretinopathy</mesh_term>
	<mesh_term>Retinal Neovascularization</mesh_term>
	<criteria>Age 18 Written inform consent Willingness attend followup visit Central serous chorioretinopathy affect visual acuity Macular edema branch retinal vein occlusion Macular edema diabetic microangiopathy Agerelated macular degeneration confluent soft drusen Agerelated macular degeneration geographic atrophy Exclusion Criteria Macular ischemia Retinal hemorrhage impede retinal laser treatment Subretinal neovascular membrane Vitreous hemorrhage Allergy fluorescein Participation clinical trial</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>selective laser therapy</keyword>
	<keyword>retinal pigment epithelium</keyword>
	<keyword>macular edema</keyword>
	<keyword>diabetic retinopathy</keyword>
	<keyword>central serous chorioretinopathy</keyword>
	<keyword>age-related macular degeneration</keyword>
	<keyword>retinal vein occlusion</keyword>
</DOC>